tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CLLS Stock Latest News

Cellectis S.A. Updates UCART Pipeline with Phase 2 Trial Details
Company AnnouncementsCellectis S.A. Updates UCART Pipeline with Phase 2 Trial Details
11d ago
6K
CLLS
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
25d ago
ALT
CLLS
Cellectis Reports 2024 Financial Results and Strategic Advances
PremiumCompany Announcements
Cellectis Reports 2024 Financial Results and Strategic Advances
27d ago
CLLS
Cellectis S.A. Earnings Call Highlights Strategic Growth
PremiumCompany Announcements
Cellectis S.A. Earnings Call Highlights Strategic Growth
27d ago
CLLS
Cellectis SA: Strategic Collaborations and Clinical Advancements Drive Buy Rating
PremiumRatings
Cellectis SA: Strategic Collaborations and Clinical Advancements Drive Buy Rating
28d ago
CLLS
Cellectis reports Q4 EPS (64c) vs (17c) last year
PremiumThe FlyCellectis reports Q4 EPS (64c) vs (17c) last year
28d ago
AZN
CLLS
Cellectis Unveils Innovative ‘Smart CAR T’ Strategy to Boost Solid Tumor Therapy
Premium
Company Announcements
Cellectis Unveils Innovative ‘Smart CAR T’ Strategy to Boost Solid Tumor Therapy
2M ago
6K
CLLS
Iovance Biotherapeutics (IOVA) Forecasts Strong Growth Due to Flagship Treatment
Premium
Market News
Iovance Biotherapeutics (IOVA) Forecasts Strong Growth Due to Flagship Treatment
2M ago
NVS
CLLS
Cellectis files to sell 44M ordinary shares for holders
PremiumThe Fly
Cellectis files to sell 44M ordinary shares for holders
3M ago
CLLS
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
BLRX
CLLS
Cellectis Secures Final Tranche of EIB Credit Facility for CAR T-Cell Development
PremiumCompany Announcements
Cellectis Secures Final Tranche of EIB Credit Facility for CAR T-Cell Development
4M ago
6K
CLLS
Cellectis S.A. Reports Q3 2024 Financial Results and Updates
PremiumCompany Announcements
Cellectis S.A. Reports Q3 2024 Financial Results and Updates
5M ago
CLLS
Cellectis SA Advances CAR T-cell Therapy for Solid Tumors
PremiumCompany AnnouncementsCellectis SA Advances CAR T-cell Therapy for Solid Tumors
5M ago
6K
CLLS
Cellectis price target lowered to $5 from $7 at Barclays
Premium
The Fly
Cellectis price target lowered to $5 from $7 at Barclays
5M ago
CLLS
Cellectis reports Q3 EPS (22c), consensus (21c)
Premium
The Fly
Cellectis reports Q3 EPS (22c), consensus (21c)
5M ago
CLLS
Cellectis S.A. Releases Interim Financial Results
PremiumCompany Announcements
Cellectis S.A. Releases Interim Financial Results
5M ago
6K
CLLS
CLLS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CLLS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
CLLS
Cellectis SA to Unveil Q3 2024 Financial Results
PremiumCompany Announcements
Cellectis SA to Unveil Q3 2024 Financial Results
5M ago
6K
CLLS
Cellectis Presents New Gene-Editing Breakthroughs
PremiumCompany Announcements
Cellectis Presents New Gene-Editing Breakthroughs
6M ago
6K
CLLS
Cellectis’ Breakthrough in TNBC Therapy
PremiumCompany AnnouncementsCellectis’ Breakthrough in TNBC Therapy
7M ago
6K
CLLS
Cellectis publishes pre-clinical evidence MUC1 CAR T-cells reducing certain BC
Premium
The Fly
Cellectis publishes pre-clinical evidence MUC1 CAR T-cells reducing certain BC
7M ago
CLLS
Cellectis Reveals Promising Cancer Therapy Breakthrough
Premium
Company Announcements
Cellectis Reveals Promising Cancer Therapy Breakthrough
8M ago
6K
CLLS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >